Low back pain may be difficult to self-manage, study says Self-management has small effects on pain and disability in people with low back pain, according to a study published online in Arthritis Care & Research.
FDA and EMA Accepts Applications for New Nusinersen Regimen
January 23rd 2025An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower FDA-approved dosage.
Read More